Decreased apoptosis in polyamine depleted IEC-6 cells depends on Akt-mediated NF-kappaB activation but not GSK3beta activity

Apoptosis. 2005 Aug;10(4):759-76. doi: 10.1007/s10495-005-2943-3.

Abstract

The PI3-kinase/Akt pathway promotes cell survival in many different cell types including intestinal epithelial cells. Increased AKT activation in polyamine depleted intestinal epithelial cells correlated well with the decrease in TNF-alpha-induced apoptosis. Increased Akt activation and GSK3beta (Ser 9) phosphorylation without significant effect on Bad (Ser136) phosphorylation indicate that Akt-mediated protection is independent of Bad phosphorylation but may depend on GSK3beta. Pretreatment of polyamine-depleted cells with LY294002 increased caspase-9 and caspase-3 activation and decreased basal levels of GSK-3beta phosphorylation. Inhibition of GSK3beta activity using AR-A014418 or lithium chloride or siRNA-mediated downregulation of its expression had no effect on apoptosis. Inhibition of PI3-kinase and over-expression of dominant negative Akt (DN-AKT), significantly increased apoptosis in polyamine depleted cells. DN-Akt expression reversed the protective effect of polyamine depletion on apoptosis. DN-Akt, as well as the PI3-kinase inhibitors, prevented Akt activation and subsequent translocation of NF-kappaB to the nucleus. Constitutively active Akt (CA-AKT) expression increased resistance to TNF-alpha-induced apoptosis. Constitutively active-Akt expression increased nuclear staining of NF-kappaB. Moreover, polyamine depletion of DN-Akt cells prevented basal and TNF-alpha-induced IkappaBalpha phosphorylation. Prevention of NF-kappaB activation in DN-IkappaBalpha-transfected cells increased apoptosis in control cells and restored it in polyamine-depleted cells to control levels. These data indicate that Akt regulates the mitochondrial pathway, preventing activation of caspase-9 and thereby caspase-3 via NF-kappaB and these effects are independent of GSK-3beta activity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Androstadienes / pharmacology
  • Animals
  • Apoptosis* / drug effects
  • Caspase 3 / metabolism
  • Caspase 9 / metabolism
  • Cell Line
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Chromones / pharmacology
  • Eflornithine / pharmacology
  • Enzyme Activation / drug effects
  • Genes, Dominant
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors
  • Glycogen Synthase Kinase 3 / metabolism
  • Glycogen Synthase Kinase 3 beta
  • I-kappa B Proteins / metabolism
  • Morpholines / pharmacology
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation / drug effects
  • Phosphoserine / metabolism
  • Polyamines / metabolism*
  • Protein Transport / drug effects
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Rats
  • Tumor Necrosis Factor-alpha / pharmacology
  • Wortmannin
  • bcl-Associated Death Protein / metabolism

Substances

  • Androstadienes
  • Chromones
  • I-kappa B Proteins
  • Morpholines
  • NF-kappa B
  • Nfkbia protein, rat
  • Phosphoinositide-3 Kinase Inhibitors
  • Polyamines
  • Tumor Necrosis Factor-alpha
  • bcl-Associated Death Protein
  • NF-KappaB Inhibitor alpha
  • Phosphoserine
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, rat
  • Proto-Oncogene Proteins c-akt
  • Glycogen Synthase Kinase 3
  • Caspase 3
  • Caspase 9
  • Wortmannin
  • Eflornithine